Job offersmore »
- Global Segment Marketing Manager Vegetables
- Agronomist or Agricultural Engineer in Luxembourg or Georgia
- Nursery Project Coordinator Luxembourg
- Sales and Customer Support - New Zealand
- General Manager - Ontario
- SALES MANAGER - France
- KEY ACCOUNT MANAGER (Fresh Cut) – France
- Marketing Manager - Beamsville, Ontario, Canada
- Key Account Manager Horticulture LED - Netherlands
- European Sales Manager – Based London or Europe
Top 5 - yesterday
- Canada: Trudeau put to work at new Lufa Farms greenhouse
- US: Coalition for Sustainable Organics advocates for organic hydroponics
- US: "Nature Fresh in discussions to build greenhouse facilities in Maine"
- NL: Chinese-style solar greenhouse about to open at WUR
- "3% more cucumbers with high-wire cultivation under lights"
Top 5 - last week
Top 5 - last month
Exchange ratesmore »
US: Cannabis Science CEO to speak at Harvard Medical SchoolCannabis Science's President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Additionally, Cannabis Science's Chief Medical Officer (CMO), Allen Herman, will Co-Chair a special session at the GHC Summit. Both Dabney and Herman previously presented at Harvard Medical School in November 2016.
Dabney will be the keynote speaker and a panelist for a special session on "Cannabis Science Versus Cancer and Other Malignancies." Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science's vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.
Additionally, Dabney will present summit participants with an overview of the company's current drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). In addition to co-chairing the session, Herman will participate in the discussion on the epidemiology of cancer and the utilization of opioids in Africa as opioid utilization rates reflect the pain divide. This conference affords Cannabis Science an opportunity to discuss cutting-edge cannabinoid research with some of the greatest minds in modern medicine globally, as well as to network and explore potential partnerships. In addition, through participation in this Summit, Cannabis Science will give updates on progress in the implementation of Cannabis Science's research agreement with Dana-Farber and a potential consortium agreement involving other institutions.
On January 3, 2017, Cannabis Science entered into a CRA with Dana-Farber, one of the world's leading cancer centers. Under the terms of the CRA, Cannabis Science and Dana-Farber will jointly investigate and develop use of cannabinoids to treat various forms of cancers.
"I am excited about Cannabis Science's relationship with Dana-Farber. When I first met Wilfred Ngwa, PhD, Director of Global Health Catalyst at Harvard Medical School and Principal Investigator for the CRA, we immediately realized potential synergies on cancer research interests, and the potential to collaborate to develop cannabinoid-based medicines to treat cancer and control cancer symptoms with minimal side-effects," stated Dabney.
Dabney and Ngwa met during the Constituency for Africa's (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC in September 2016, where they both were on the speaking program. Mr. Dabney is a Member of the Board of Directors of CFA, and the Vice Chairman of CFA's African Healthcare Infrastructure Committee (AHIC).
For more information:
Publication date: 3/8/2017
Other news in this sector: